サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1356228

世界の計算医学と創薬ソフトウェア市場：考察と予測 (2029年まで)

Global Computational Medicine and Drug Designing Software Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の計算医学と創薬ソフトウェア市場：考察と予測 (2029年まで)
出版日: 2023年10月05日
発行: QYResearch
ページ情報: 英文 114 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、計算医学と創薬ソフトウェア (Computational Medicine and Drug Designing Software) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の計算医学と創薬ソフトウェアの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Cloud-based
    • On-premise
  • 市場：用途別
    • 世界の計算医学と創薬ソフトウェアの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Drug Discovery and Development
    • Computational Physiological Medicine
    • Disease Modeling
    • Medical Imaging
    • Predictive Analysis of Drug Targets
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の計算医学と創薬ソフトウェアの市場展望 (2018-2029)
  • 世界の計算医学と創薬ソフトウェアの市場成長トレンド：地域別
    • 計算医学と創薬ソフトウェア 市場規模：地域別: 2018 VS 2022 VS 2029
    • 計算医学と創薬ソフトウェアの市場規模実績：地域別 (2018-2023)
    • 計算医学と創薬ソフトウェアの市場規模予測：地域別 (2024-2029)
  • 計算医学と創薬ソフトウェア 市場動向
    • 計算医学と創薬ソフトウェア 業界動向
    • 計算医学と創薬ソフトウェア 市場の促進要因
    • 計算医学と創薬ソフトウェア 市場の課題
    • 計算医学と創薬ソフトウェア 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 計算医学と創薬ソフトウェア ：競合別
    • 世界の計算医学と創薬ソフトウェアの収益：企業別 (2018-2023)
    • 世界の計算医学と創薬ソフトウェアの収益シェア：企業別 (2018-2023)
  • 世界の計算医学と創薬ソフトウェアの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 計算医学と創薬ソフトウェア, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の計算医学と創薬ソフトウェア 市場集中度
    • 世界の計算医学と創薬ソフトウェア 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 計算医学と創薬ソフトウェアの収益 2022
  • 世界の主要企業 計算医学と創薬ソフトウェア 本社 および提供地域
  • 世界の主要企業 計算医学と創薬ソフトウェア, 製品およびアプリケーション
  • 世界の主要企業 計算医学と創薬ソフトウェア, 業界参入時期
  • M&A, 拡張計画

第4章 計算医学と創薬ソフトウェア 内訳データ：タイプ別

  • 世界の計算医学と創薬ソフトウェアの市場規模実績：タイプ別 (2018-2023)
  • 世界の計算医学と創薬ソフトウェアの市場規模予測：タイプ別 (2024-2029)

第5章 計算医学と創薬ソフトウェア 内訳データ：用途別

  • 世界の計算医学と創薬ソフトウェアの市場規模実績：用途別 (2018-2023)
  • 世界の計算医学と創薬ソフトウェアの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の計算医学と創薬ソフトウェア 市場規模 (2018-2029)
  • 北米の計算医学と創薬ソフトウェア 市場規模：タイプ別
    • 北米の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 北米の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 北米の計算医学と創薬ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 北米の計算医学と創薬ソフトウェア 市場規模：用途別
    • 北米の計算医学と創薬ソフトウェア 市場規模：用途別 (2018-2023)
    • 北米の計算医学と創薬ソフトウェア 市場規模：用途別 (2024-2029)
    • 北米の計算医学と創薬ソフトウェアの市場シェア：用途別 (2018-2029)
  • 北米の計算医学と創薬ソフトウェア 市場規模：国別
    • 北米の計算医学と創薬ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の計算医学と創薬ソフトウェア 市場規模：国別 (2018-2023)
    • 北米の計算医学と創薬ソフトウェア 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の計算医学と創薬ソフトウェア 市場規模 (2018-2029)
  • 欧州の計算医学と創薬ソフトウェア 市場規模：タイプ別
    • 欧州の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 欧州の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 欧州の計算医学と創薬ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 欧州の計算医学と創薬ソフトウェア 市場規模：用途別
    • 欧州の計算医学と創薬ソフトウェア 市場規模：用途別 (2018-2023)
    • 欧州の計算医学と創薬ソフトウェア 市場規模：用途別 (2024-2029)
    • 欧州の計算医学と創薬ソフトウェアの市場シェア：用途別 (2018-2029)
  • 欧州の計算医学と創薬ソフトウェア 市場規模：国別
    • 欧州の計算医学と創薬ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の計算医学と創薬ソフトウェア 市場規模：国別 (2018-2023)
    • 欧州の計算医学と創薬ソフトウェア 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の計算医学と創薬ソフトウェア 市場規模 (2018-2029)
  • 中国の計算医学と創薬ソフトウェア 市場規模：タイプ別
    • 中国の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 中国の計算医学と創薬ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 中国の計算医学と創薬ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 中国の計算医学と創薬ソフトウェア 市場規模：用途別
    • 中国の計算医学と創薬ソフトウェア 市場規模：用途別 (2018-2023)
    • 中国の計算医学と創薬ソフトウェア 市場規模：用途別 (2024-2029)
    • 中国の計算医学と創薬ソフトウェアの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 計算医学と創薬ソフトウェア 市場規模 (2018-2029)
  • アジア地域 計算医学と創薬ソフトウェア 市場規模：タイプ別
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：タイプ別 (2018-2023)
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：タイプ別 (2024-2029)
    • アジア地域 計算医学と創薬ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • アジア地域 計算医学と創薬ソフトウェア 市場規模：用途別
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：用途別 (2018-2023)
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：用途別 (2024-2029)
    • アジア地域 計算医学と創薬ソフトウェアの市場シェア：用途別 (2018-2029)
  • アジア地域 計算医学と創薬ソフトウェア 市場規模：地域別
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：地域別 (2018-2023)
    • アジア地域 計算医学と創薬ソフトウェア 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：タイプ別
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：用途別
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェアの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：国別
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 計算医学と創薬ソフトウェア 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Entelos
  • Crown Bioscience
  • Chemical Computing Group
  • Nimbus Therapeutics
  • Schrodinger
  • Dassault Systemes
  • Genedata
  • Biognos
  • Leadscope
  • Rhenovia Pharma Limited
  • Compugen
  • Certara LP
  • Prosarix
  • Simulations Plus
  • Strand Life Sciences

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Cloud-based
  • Table 3. Key Players of On-premise
  • Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 5. Global Computational Medicine and Drug Designing Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2018-2023)
  • Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2024-2029)
  • Table 10. Computational Medicine and Drug Designing Software Market Trends
  • Table 11. Computational Medicine and Drug Designing Software Market Drivers
  • Table 12. Computational Medicine and Drug Designing Software Market Challenges
  • Table 13. Computational Medicine and Drug Designing Software Market Restraints
  • Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2018-2023) & (US$ Million)
  • Table 15. Global Computational Medicine and Drug Designing Software Revenue Share by Players (2018-2023)
  • Table 16. Global Top Computational Medicine and Drug Designing Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2022)
  • Table 17. Global Computational Medicine and Drug Designing Software Industry Ranking 2021 VS 2022 VS 2023
  • Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2018-2023)
  • Table 19. Global Key Players of Computational Medicine and Drug Designing Software, Headquarters and Area Served
  • Table 20. Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
  • Table 21. Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2018-2023)
  • Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2024-2029)
  • Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 28. Global Computational Medicine and Drug Designing Software Revenue Share by Application (2018-2023)
  • Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. Global Computational Medicine and Drug Designing Software Revenue Share by Application (2024-2029)
  • Table 31. North America Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 32. North America Computational Medicine and Drug Designing Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 33. North America Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 34. North America Computational Medicine and Drug Designing Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 35. North America Computational Medicine and Drug Designing Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 36. North America Computational Medicine and Drug Designing Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 37. North America Computational Medicine and Drug Designing Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 38. Europe Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 39. Europe Computational Medicine and Drug Designing Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 40. Europe Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 41. Europe Computational Medicine and Drug Designing Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 42. Europe Computational Medicine and Drug Designing Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 43. Europe Computational Medicine and Drug Designing Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 44. Europe Computational Medicine and Drug Designing Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 45. China Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 46. China Computational Medicine and Drug Designing Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 47. China Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 48. China Computational Medicine and Drug Designing Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 49. Asia Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 50. Asia Computational Medicine and Drug Designing Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 51. Asia Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 52. Asia Computational Medicine and Drug Designing Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 53. Asia Computational Medicine and Drug Designing Software Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 54. Asia Computational Medicine and Drug Designing Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 55. Asia Computational Medicine and Drug Designing Software Market Size by Region (2024-2029) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 61. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 63. Entelos Company Details
  • Table 64. Entelos Business Overview
  • Table 65. Entelos Computational Medicine and Drug Designing Software Product
  • Table 66. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 67. Entelos Recent Developments
  • Table 68. Crown Bioscience Company Details
  • Table 69. Crown Bioscience Business Overview
  • Table 70. Crown Bioscience Computational Medicine and Drug Designing Software Product
  • Table 71. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 72. Crown Bioscience Recent Developments
  • Table 73. Chemical Computing Group Company Details
  • Table 74. Chemical Computing Group Business Overview
  • Table 75. Chemical Computing Group Computational Medicine and Drug Designing Software Product
  • Table 76. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 77. Chemical Computing Group Recent Developments
  • Table 78. Nimbus Therapeutics Company Details
  • Table 79. Nimbus Therapeutics Business Overview
  • Table 80. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product
  • Table 81. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 82. Nimbus Therapeutics Recent Developments
  • Table 83. Schrodinger Company Details
  • Table 84. Schrodinger Business Overview
  • Table 85. Schrodinger Computational Medicine and Drug Designing Software Product
  • Table 86. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 87. Schrodinger Recent Developments
  • Table 88. Dassault Systemes Company Details
  • Table 89. Dassault Systemes Business Overview
  • Table 90. Dassault Systemes Computational Medicine and Drug Designing Software Product
  • Table 91. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 92. Dassault Systemes Recent Developments
  • Table 93. Genedata Company Details
  • Table 94. Genedata Business Overview
  • Table 95. Genedata Computational Medicine and Drug Designing Software Product
  • Table 96. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 97. Genedata Recent Developments
  • Table 98. Biognos Company Details
  • Table 99. Biognos Business Overview
  • Table 100. Biognos Computational Medicine and Drug Designing Software Product
  • Table 101. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 102. Biognos Recent Developments
  • Table 103. Leadscope Company Details
  • Table 104. Leadscope Business Overview
  • Table 105. Leadscope Computational Medicine and Drug Designing Software Product
  • Table 106. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 107. Leadscope Recent Developments
  • Table 108. Rhenovia Pharma Limited Company Details
  • Table 109. Rhenovia Pharma Limited Business Overview
  • Table 110. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product
  • Table 111. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 112. Rhenovia Pharma Limited Recent Developments
  • Table 113. Compugen Company Details
  • Table 114. Compugen Business Overview
  • Table 115. Compugen Computational Medicine and Drug Designing Software Product
  • Table 116. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 117. Compugen Recent Developments
  • Table 118. Certara LP Company Details
  • Table 119. Certara LP Business Overview
  • Table 120. Certara LP Computational Medicine and Drug Designing Software Product
  • Table 121. Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 122. Certara LP Recent Developments
  • Table 123. Prosarix Company Details
  • Table 124. Prosarix Business Overview
  • Table 125. Prosarix Computational Medicine and Drug Designing Software Product
  • Table 126. Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 127. Prosarix Recent Developments
  • Table 128. Simulations Plus Company Details
  • Table 129. Simulations Plus Business Overview
  • Table 130. Simulations Plus Computational Medicine and Drug Designing Software Product
  • Table 131. Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 132. Simulations Plus Recent Developments
  • Table 133. Strand Life Sciences Company Details
  • Table 134. Strand Life Sciences Business Overview
  • Table 135. Strand Life Sciences Computational Medicine and Drug Designing Software Product
  • Table 136. Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2018-2023) & (US$ Million)
  • Table 137. Strand Life Sciences Recent Developments
  • Table 138. Research Programs/Design for This Report
  • Table 139. Key Data Information from Secondary Sources
  • Table 140. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Computational Medicine and Drug Designing Software Market Share by Type: 2022 VS 2029
  • Figure 3. Cloud-based Features
  • Figure 4. On-premise Features
  • Figure 5. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 6. Global Computational Medicine and Drug Designing Software Market Share by Application: 2022 VS 2029
  • Figure 7. Drug Discovery and Development Case Studies
  • Figure 8. Computational Physiological Medicine Case Studies
  • Figure 9. Disease Modeling Case Studies
  • Figure 10. Medical Imaging Case Studies
  • Figure 11. Predictive Analysis of Drug Targets Case Studies
  • Figure 12. Computational Medicine and Drug Designing Software Report Years Considered
  • Figure 13. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 14. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Computational Medicine and Drug Designing Software Market Share by Region: 2022 VS 2029
  • Figure 16. Global Computational Medicine and Drug Designing Software Market Share by Players in 2022
  • Figure 17. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2022)
  • Figure 18. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2022
  • Figure 19. North America Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 20. North America Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • Figure 21. North America Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • Figure 22. North America Computational Medicine and Drug Designing Software Market Share by Country (2018-2029)
  • Figure 23. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Europe Computational Medicine and Drug Designing Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 26. Europe Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • Figure 27. Europe Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • Figure 28. Europe Computational Medicine and Drug Designing Software Market Share by Country (2018-2029)
  • Figure 29. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. China Computational Medicine and Drug Designing Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 36. China Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • Figure 37. China Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • Figure 38. Asia Computational Medicine and Drug Designing Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 39. Asia Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • Figure 40. Asia Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • Figure 41. Asia Computational Medicine and Drug Designing Software Market Share by Region (2018-2029)
  • Figure 42. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. China Taiwan Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Country (2018-2029)
  • Figure 52. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Israel Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. GCC Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 59. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 60. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 61. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 62. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 63. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 64. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 65. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 66. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 67. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 68. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 69. Certara LP Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 70. Prosarix Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 71. Simulations Plus Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 72. Strand Life Sciences Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2018-2023)
  • Figure 73. Bottom-up and Top-down Approaches for This Report
  • Figure 74. Data Triangulation
  • Figure 75. Key Executives Interviewed
目次

This research report focuses on the Computational Medicine and Drug Designing Software Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Cloud-based
    • 1.2.3 On-premise
  • 1.3 Market by Application
    • 1.3.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Drug Discovery and Development
    • 1.3.3 Computational Physiological Medicine
    • 1.3.4 Disease Modeling
    • 1.3.5 Medical Imaging
    • 1.3.6 Predictive Analysis of Drug Targets
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2018-2029)
  • 2.2 Global Computational Medicine and Drug Designing Software Growth Trends by Region
    • 2.2.1 Computational Medicine and Drug Designing Software Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2018-2023)
    • 2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2024-2029)
  • 2.3 Computational Medicine and Drug Designing Software Market Dynamics
    • 2.3.1 Computational Medicine and Drug Designing Software Industry Trends
    • 2.3.2 Computational Medicine and Drug Designing Software Market Drivers
    • 2.3.3 Computational Medicine and Drug Designing Software Market Challenges
    • 2.3.4 Computational Medicine and Drug Designing Software Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Computational Medicine and Drug Designing Software by Players
    • 3.1.1 Global Computational Medicine and Drug Designing Software Revenue by Players (2018-2023)
    • 3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2018-2023)
  • 3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Computational Medicine and Drug Designing Software, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
    • 3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2022
  • 3.5 Global Key Players of Computational Medicine and Drug Designing Software Head office and Area Served
  • 3.6 Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
  • 3.7 Global Key Players of Computational Medicine and Drug Designing Software, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Medicine and Drug Designing Software Breakdown Data by Type

  • 4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2018-2023)
  • 4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2024-2029)

5 Computational Medicine and Drug Designing Software Breakdown Data by Application

  • 5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2018-2023)
  • 5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Computational Medicine and Drug Designing Software Market Size (2018-2029)
  • 6.2 North America Computational Medicine and Drug Designing Software Market Size by Type
    • 6.2.1 North America Computational Medicine and Drug Designing Software Market Size by Type (2018-2023)
    • 6.2.2 North America Computational Medicine and Drug Designing Software Market Size by Type (2024-2029)
    • 6.2.3 North America Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • 6.3 North America Computational Medicine and Drug Designing Software Market Size by Application
    • 6.3.1 North America Computational Medicine and Drug Designing Software Market Size by Application (2018-2023)
    • 6.3.2 North America Computational Medicine and Drug Designing Software Market Size by Application (2024-2029)
    • 6.3.3 North America Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • 6.4 North America Computational Medicine and Drug Designing Software Market Size by Country
    • 6.4.1 North America Computational Medicine and Drug Designing Software Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Computational Medicine and Drug Designing Software Market Size by Country (2018-2023)
    • 6.4.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Computational Medicine and Drug Designing Software Market Size (2018-2029)
  • 7.2 Europe Computational Medicine and Drug Designing Software Market Size by Type
    • 7.2.1 Europe Computational Medicine and Drug Designing Software Market Size by Type (2018-2023)
    • 7.2.2 Europe Computational Medicine and Drug Designing Software Market Size by Type (2024-2029)
    • 7.2.3 Europe Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • 7.3 Europe Computational Medicine and Drug Designing Software Market Size by Application
    • 7.3.1 Europe Computational Medicine and Drug Designing Software Market Size by Application (2018-2023)
    • 7.3.2 Europe Computational Medicine and Drug Designing Software Market Size by Application (2024-2029)
    • 7.3.3 Europe Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • 7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country
    • 7.4.1 Europe Computational Medicine and Drug Designing Software Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Computational Medicine and Drug Designing Software Market Size by Country (2018-2023)
    • 7.4.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Computational Medicine and Drug Designing Software Market Size (2018-2029)
  • 8.2 China Computational Medicine and Drug Designing Software Market Size by Type
    • 8.2.1 China Computational Medicine and Drug Designing Software Market Size by Type (2018-2023)
    • 8.2.2 China Computational Medicine and Drug Designing Software Market Size by Type (2024-2029)
    • 8.2.3 China Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • 8.3 China Computational Medicine and Drug Designing Software Market Size by Application
    • 8.3.1 China Computational Medicine and Drug Designing Software Market Size by Application (2018-2023)
    • 8.3.2 China Computational Medicine and Drug Designing Software Market Size by Application (2024-2029)
    • 8.3.3 China Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Computational Medicine and Drug Designing Software Market Size (2018-2029)
  • 9.2 Asia Computational Medicine and Drug Designing Software Market Size by Type
    • 9.2.1 Asia Computational Medicine and Drug Designing Software Market Size by Type (2018-2023)
    • 9.2.2 Asia Computational Medicine and Drug Designing Software Market Size by Type (2024-2029)
    • 9.2.3 Asia Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • 9.3 Asia Computational Medicine and Drug Designing Software Market Size by Application
    • 9.3.1 Asia Computational Medicine and Drug Designing Software Market Size by Application (2018-2023)
    • 9.3.2 Asia Computational Medicine and Drug Designing Software Market Size by Application (2024-2029)
    • 9.3.3 Asia Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • 9.4 Asia Computational Medicine and Drug Designing Software Market Size by Region
    • 9.4.1 Asia Computational Medicine and Drug Designing Software Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Computational Medicine and Drug Designing Software Market Size by Region (2018-2023)
    • 9.4.3 Asia Computational Medicine and Drug Designing Software Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Entelos
    • 11.1.1 Entelos Company Details
    • 11.1.2 Entelos Business Overview
    • 11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
    • 11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.1.5 Entelos Recent Developments
  • 11.2 Crown Bioscience
    • 11.2.1 Crown Bioscience Company Details
    • 11.2.2 Crown Bioscience Business Overview
    • 11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
    • 11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.2.5 Crown Bioscience Recent Developments
  • 11.3 Chemical Computing Group
    • 11.3.1 Chemical Computing Group Company Details
    • 11.3.2 Chemical Computing Group Business Overview
    • 11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
    • 11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.3.5 Chemical Computing Group Recent Developments
  • 11.4 Nimbus Therapeutics
    • 11.4.1 Nimbus Therapeutics Company Details
    • 11.4.2 Nimbus Therapeutics Business Overview
    • 11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
    • 11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.4.5 Nimbus Therapeutics Recent Developments
  • 11.5 Schrodinger
    • 11.5.1 Schrodinger Company Details
    • 11.5.2 Schrodinger Business Overview
    • 11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
    • 11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.5.5 Schrodinger Recent Developments
  • 11.6 Dassault Systemes
    • 11.6.1 Dassault Systemes Company Details
    • 11.6.2 Dassault Systemes Business Overview
    • 11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
    • 11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.6.5 Dassault Systemes Recent Developments
  • 11.7 Genedata
    • 11.7.1 Genedata Company Details
    • 11.7.2 Genedata Business Overview
    • 11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
    • 11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.7.5 Genedata Recent Developments
  • 11.8 Biognos
    • 11.8.1 Biognos Company Details
    • 11.8.2 Biognos Business Overview
    • 11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
    • 11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.8.5 Biognos Recent Developments
  • 11.9 Leadscope
    • 11.9.1 Leadscope Company Details
    • 11.9.2 Leadscope Business Overview
    • 11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
    • 11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.9.5 Leadscope Recent Developments
  • 11.10 Rhenovia Pharma Limited
    • 11.10.1 Rhenovia Pharma Limited Company Details
    • 11.10.2 Rhenovia Pharma Limited Business Overview
    • 11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
    • 11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.10.5 Rhenovia Pharma Limited Recent Developments
  • 11.11 Compugen
    • 11.11.1 Compugen Company Details
    • 11.11.2 Compugen Business Overview
    • 11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
    • 11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.11.5 Compugen Recent Developments
  • 11.12 Certara LP
    • 11.12.1 Certara LP Company Details
    • 11.12.2 Certara LP Business Overview
    • 11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction
    • 11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.12.5 Certara LP Recent Developments
  • 11.13 Prosarix
    • 11.13.1 Prosarix Company Details
    • 11.13.2 Prosarix Business Overview
    • 11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction
    • 11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.13.5 Prosarix Recent Developments
  • 11.14 Simulations Plus
    • 11.14.1 Simulations Plus Company Details
    • 11.14.2 Simulations Plus Business Overview
    • 11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction
    • 11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.14.5 Simulations Plus Recent Developments
  • 11.15 Strand Life Sciences
    • 11.15.1 Strand Life Sciences Company Details
    • 11.15.2 Strand Life Sciences Business Overview
    • 11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction
    • 11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2018-2023)
    • 11.15.5 Strand Life Sciences Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details